Chemical Compound Review:
Calcium oxalate monohydrate calcium ethanedioate hydrate
Synonyms:
ACMC-1BMV0, AG-E-74483, AC1L4WJI, CTK4F4429, AR-1I1613, ...
This record was replaced with 971.
- Reduced crystallization inhibition by urine from women with nephrolithiasis. Asplin, J.R., Parks, J.H., Nakagawa, Y., Coe, F.L. Kidney Int. (2002)
- Evaluation of synchronous twin pulse technique for shock wave lithotripsy: determination of optimal parameters for in vitro stone fragmentation. Sheir, K.Z., Zabihi, N., Lee, D., Teichman, J.M., Rehman, J., Sundaram, C.P., Heimbach, D., Hesse, A., Delvecchio, F., Zhong, P., Preminger, G.M., Clayman, R.V. J. Urol. (2003)
- Expression profiling of crystal-induced injury in human kidney epithelial cells. Liang, L., Chen, J., Vittal, R., Selvanayagam, Z.E., McAteer, J.A., Deng, L., Tischfield, J., Chin, K.V., Sahota, A. Nephron. Physiology [electronic resource]. (2006)
- COM crystals activate the p38 mitogen-activated protein kinase signal transduction pathway in renal epithelial cells. Koul, H.K., Menon, M., Chaturvedi, L.S., Koul, S., Sekhon, A., Bhandari, A., Huang, M. J. Biol. Chem. (2002)
- Nucleation at surfaces: the importance of interfacial energy. Wu, W., Gerard, D.E., Nancollas, G.H. J. Am. Soc. Nephrol. (1999)
- Urinary macromolecular inhibition of crystal adhesion to renal epithelial cells is impaired in male stone formers. Kumar, V., Peña de la Vega, L., Farell, G., Lieske, J.C. Kidney Int. (2005)
- Properties and function of nephrocalcin: mechanism of kidney stone inhibition or promotion. Nakagawa, Y. The Keio journal of medicine. (1997)
- Sex- and age-related composition of 10 617 calculi analyzed by infrared spectroscopy. Daudon, M., Donsimoni, R., Hennequin, C., Fellahi, S., Le Moel, G., Paris, M., Troupel, S., Lacour, B. Urol. Res. (1995)
- Morphological and immunological characteristics of nanobacteria from human renal stones of a north Indian population. Khullar, M., Sharma, S.K., Singh, S.K., Bajwa, P., Sheikh, F.A., Relan, V., Sharma, M. Urol. Res. (2004)
- Urinary crystallization inhibitors do not prevent crystal binding. Schepers, M.S., van der Boom, B.G., Romijn, J.C., Schröder, F.H., Verkoelen, C.F. J. Urol. (2002)
- Inhibitors within the nephron. Coe, F.L., Nakagawa, Y., Parks, J.H. Am. J. Kidney Dis. (1991)
- Tamm-Horsfall protein excretion and its relation to citrate in urine of stone-forming patients. Ganter, K., Bongartz, D., Hesse, A. Urology (1999)
- Study of the effects of different substances on the early stages of papillary stone formation. Grases, F., Garcia-Ferragut, L., Costa-Bauzá, A., March, J.G. Nephron (1996)
- Cell-crystal interactions and kidney stone formation. Lieske, J.C., Deganello, S., Toback, F.G. Nephron (1999)
- Encrustation of a metal alloy urinary stent: a mechanistic investigation. Barbalias, G.A., Bouropoulos, C., Vagenas, N.V., Bouropoulos, N., Siablis, D., Liatsikos, E.N., Karnabatidis, D., Koutsoukos, P.G. Eur. Urol. (2000)
- Crystallization during volume reduction of solutions with a composition corresponding to that in the collecting duct: the influence of hydroxyapatite seed crystals and urinary macromolecules. Højgaard, I., Fornander, A.M., Nilsson, M.A., Tiselius, H.G. Urol. Res. (1999)
- Factors affecting the regrowth of renal stones in vitro: a contribution to the understanding of renal stone development. Costa-Bauzá, A., Isern, B., Perelló, J., Sanchis, P., Grases, F. Scandinavian journal of urology and nephrology. (2005)